BONESUPPORT HOLDING AB NPVBONESUPPORT HOLDING AB NPVBONESUPPORT HOLDING AB NPV

BONESUPPORT HOLDING AB NPV

No trades
See on Supercharts

0RQO fundamentals

BONESUPPORT HOLDING AB NPV revenue breakdown overview

BONESUPPORT HOLDING AB NPV revenue for the last year amounted to 591.04 M SEK, the most of which — 358.24 M SEK — came from its highest performing source at the moment, Cerament Gentamicin and Ceramanent Vancomycin, the year earlier bringing 112.17 M SEK. The greatest contribution to the revenue figure was made by North America — last year it brought BONESUPPORT HOLDING AB NPV 442.45 M SEK, and the year before that — 216.88 M SEK.

By source
By country